Kimberly Page, PhD, MPH

Kimberly Page is no longer active with the UCSF-Gladstone CFAR.

  • Professor, School of Medicine

Biography

Dr. Page was formerly a Professor in Residence in the Department of Epidemiology and Biostatistics, Division of Infectious Disease, in the Department of Medicine at University of California San Francisco (UCSF). She is now Professor and Chief of Epidemiology, Biostatistics & Preventive Medicine at the University of New Mexico.  She received her Ph.D and MPH from the University of California at Berkeley and completed fellowships at the UCSF Center for AIDS Prevention Studies and the Municipal Health Service in Amsterdam, the Netherlands. She has been the PI of multiple NIH and CDC funded grants, and collaborates with researchers nationally and internationally. Dr. Page is an infectious disease epidemiologist; her research is principally focused on HIV and hepatitis C virus (HCV) infections, principally prevention, natural history, and intervention research in marginalized and underserved populations including injection drug users, and female sex workers. She is currently leading a clinical trial testing a prophylactic HCV vaccine in active injection drug users and a large implementation science trial in Cambodia to reduce drug use and HIV infection in female sex workers. She is the PI of two NIH NIDA funded studies of of HIV and HCV including: the UFO Study, an internationally recognized study of acute HCV in young adult injection drug users, and, the InC3 Collaborative, which brings together investigators and data from preeminent prospective studies of HIV and HCV globally. Dr. Page has been a faculty lead, as Director of Latin and Central America Region for the Fogarty funded International Traineeships in AIDS Prevention Studies (ITAPS) program at UCSF since 2002, providing training and capacity building to scientists from developing countries including Brazil, Argentina, Peru, Guatemala, Mexico, and from Southeast Asia, including Cambodia and Thailand. To learn more about Dr. Page please visit the links below.

Displaying 1 - 195 of 195

  1. Couture MC, Evans JL, Draughon Moret J, Stein ES, Muth S, Phou M, Len A, Ngak S, Sophal C, Neak Y, Carrico AW, Maher L, Page K. Syndemic Psychosocial Health Conditions Associated with Recent Client-Perpetrated Violence Against Female Entertainment and Sex Workers in Cambodia. Arch Sex Behav. 2020 Apr 27. View on Pubmed
  2. Boon D, Bruce V, Patel EU, Quinn J, Srikrishnan AK, Shanmugam S, Iqbal S, Balakrishnan P, Sievers M, Kirk GD, Thomas DL, Quinn TC, Cox AL, Page KA, Solomon SS, Mehta SH, Laeyendecker O. Antibody avidity-based approach to estimate population-level incidence of hepatitis C. J Hepatol. 2020 Mar 30. View on Pubmed
  3. Leyva Y, Page K, Shiboski S, Hahn JA, Evans J, Erhardt E. Per-Contact Infectivity of Hepatitis C Virus Acquisition in Association With Receptive Needle Sharing Exposures in a Prospective Cohort of Young Adult People who Inject Drugs in San Francisco, California. Open Forum Infect Dis. 2020 Apr; 7(4):ofaa092. View on Pubmed
  4. Lee JY, Page K, Stein E, Evans JL, Sokunny M, Maly P, Sophal C, Ngak S, Maher L, Carrico AW. Who's that SMARTgirl? Reaching Cambodian Female Entertainment and Sex Workers with HIV Prevention Services. AIDS Behav. 2020 Mar; 24(3):738-745. View on Pubmed
  5. Coller KE, Bruce V, Cassidy M, Gersch J, Frankel MB, Vallari A, Cloherty G, Hackett J, Evans JL, Page K, Dawson GJ. Chronic Human Pegivirus 2 without Hepatitis C Virus Co-infection. Emerg Infect Dis. 2020 Feb; 26(2):265-272. View on Pubmed
  6. Geddes L, Iversen J, Wand H, Esmaeili A, Tsui J, Hellard M, Dore G, Grebely J, Dietze P, Bruneau J, Prins M, Morris MD, Shoukry NH, Lloyd AR, Kim AY, Lauer G, Cox AL, Page K, Maher L. Sex Discrepancies in the Protective Effect of Opioid Agonist Therapy on Incident Hepatitis C Infection. Clin Infect Dis. 2020 Jan 01; 70(1):123-131. View on Pubmed
  7. Page K, Evans JL, Hahn JA, Vickerman P, Shiboski S, Morris MD. HCV incidence is associated with injecting partner age and HCV serostatus mixing in young adults who inject drugs in San Francisco. PLoS One. 2019; 14(12):e0226166. View on Pubmed
  8. Litwin AH, Jost J, Wagner K, Heo M, Karasz A, Feinberg J, Kim AY, Lum PJ, Mehta SH, Taylor LE, Tsui JI, Pericot-Valverde I, Page K. Rationale and design of a randomized pragmatic trial of patient-centered models of hepatitis C treatment for people who inject drugs: The HERO study. Contemp Clin Trials. 2019 Dec; 87:105859. View on Pubmed
  9. Page K, Qeadan F, Qualls C, Thornton K, Arora S. Project ECHO Revisited: Propensity Score Analysis And HCV Treatment Outcomes. Hepat Med. 2019; 11:149-152. View on Pubmed
  10. Barbosa C, Fraser H, Hoerger TJ, Leib A, Havens JR, Young A, Kral A, Page K, Evans J, Zibbell J, Hariri S, Vellozzi C, Nerlander L, Ward JW, Vickerman P. Cost-effectiveness of scaling-up HCV prevention and treatment in the United States for people who inject drugs. Addiction. 2019 12; 114(12):2267-2278. View on Pubmed
  11. Fraser H, Vellozzi C, Hoerger TJ, Evans JL, Kral AH, Havens J, Young AM, Stone J, Handanagic S, Hariri S, Barbosa C, Hickman M, Leib A, Martin NK, Nerlander L, Raymond HF, Page K, Zibbell J, Ward JW, Vickerman P. Scaling Up Hepatitis C Prevention and Treatment Interventions for Achieving Elimination in the United States: A Rural and Urban Comparison. Am J Epidemiol. 2019 08 01; 188(8):1539-1551. View on Pubmed
  12. Morris MD, Andrew E, Tan JY, Maher L, Hoff C, Darbes L, Page K. Injecting-related trust, cooperation, intimacy, and power as key factors influencing risk perception among drug injecting partnerships. PLoS One. 2019; 14(5):e0217811. View on Pubmed
  13. Hahn JA, Tully DC, Evans JL, Morris MD, Briceno A, Bean DJ, Allen TM, Page K. Role of HCV Viremia in Corroborated HCV Transmission Events Within Young Adult Injecting Partnerships. Open Forum Infect Dis. 2019 Apr; 6(4):ofz125. View on Pubmed
  14. Echevarria D, Gutfraind A, Boodram B, Layden J, Ozik J, Page K, Cotler SJ, Major M, Dahari H. Modeling indicates efficient vaccine-based interventions for the elimination of hepatitis C virus among persons who inject drugs in metropolitan Chicago. Vaccine. 2019 May 01; 37(19):2608-2616. View on Pubmed
  15. Abayasingam A, Leung P, Eltahla A, Bull RA, Luciani F, Grebely J, Dore GJ, Applegate T, Page K, Bruneau J, Cox AL, Kim AY, Schinkel J, Shoukry NH, Lauer GM, Maher L, Hellard M, Prins M, Lloyd A, Rodrigo C. Genomic characterization of hepatitis C virus transmitted founder variants with deep sequencing. Infect Genet Evol. 2019 07; 71:36-41. View on Pubmed
  16. Morris MD, Mirzazadeh A, Evans JL, Briceno A, Coffin P, Hahn JA, Page KA. Treatment cascade for hepatitis C virus in young adult people who inject drugs in San Francisco: Low number treated. Drug Alcohol Depend. 2019 05 01; 198:133-135. View on Pubmed
  17. Bruce V, Eldredge J, Leyva Y, Mera J, English K, Page K. Hepatitis C Virus Infection in Indigenous Populations in the United States and Canada. Epidemiol Rev. 2019 Jan 31; 41(1):158-167. View on Pubmed
  18. Carvour ML, Chiu A, Page K. Racial and ethnic disparities in surgical amputations following serious musculoskeletal infections in a diverse New Mexico cohort. J Clin Transl Res. 2019 Sep 08; 5(1):25-32. View on Pubmed
  19. Rodrigo C, Leung P, Lloyd AR, Bull RA, Luciani F, Grebely J, Dore GJ, Applegate T, Page K, Bruneau J, Cox AL, Osburn W, Kim AY, Shoukry NH, Lauer GM, Maher L, Schinkel J, Prins M, Hellard M, Eltahla AA. Genomic variability of within-host hepatitis C variants in acute infection. J Viral Hepat. 2019 04; 26(4):476-484. View on Pubmed
  20. Page K, Carrico AW, Stein E, Evans J, Sokunny M, Maly P, Sophal C, Neak Y, Ngak S, McCulloch C, Maher L. Cluster randomized stepped-wedge trial of a multi-level HIV prevention intervention to decrease amphetamine-type stimulants and sexual risk in Cambodian female entertainment and sex workers. Drug Alcohol Depend. 2019 03 01; 196:21-30. View on Pubmed
  21. Coupland H, Page K, Stein E, Carrico A, Evans J, Dixon T, Sokunny M, Phou M, Maher L. Structural interventions and social suffering: Responding to amphetamine-type stimulant use among female entertainment and sex workers in Cambodia. Int J Drug Policy. 2019 02; 64:70-78. View on Pubmed
  22. Knight LL, Wagner K, Leyva Y, Bruce VR, White KAM, Talamantes YS, Price B, Page K, Carvour ML. Talking About Hepatitis C: FAQs From Young Adults Who Inject Drugs. Health Promot Pract. 2018 11; 19(6):815-822. View on Pubmed
  23. Carvour ML, Wilder SL, Ryan KL, Walraven C, Qeadan F, Brett M, Page K. Predictors of Clostridium difficile infection and predictive impact of probiotic use in a diverse hospital-wide cohort. Am J Infect Control. 2019 01; 47(1):2-8. View on Pubmed
  24. Major M, Gutfraind A, Shekhtman L, Cui Q, Kachko A, Cotler SJ, Hajarizadeh B, Sacks-Davis R, Page K, Boodram B, Dahari H. Modeling of patient virus titers suggests that availability of a vaccine could reduce hepatitis C virus transmission among injecting drug users. Sci Transl Med. 2018 07 11; 10(449). View on Pubmed
  25. Chhim S, Chhea C, Sopheab H, Mathers BM, Kaldor J, Evans JL, Stein ES, Carrico A, Muth S, Song N, Maher L, Page K. Proportion and predictors of loss to follow-up in a longitudinal cohort study of female entertainment and sex workers in Cambodia. Int J STD AIDS. 2018 11; 29(13):1295-1304. View on Pubmed
  26. Ikeda JM, Racancoj O, Welty S, Page K, Hearst N, McFarland W. Risk Behaviors and Perceptions Among Self-identified Men Who Have Sex with Men (MSM), Bisexuals, Transvestites, and Transgender Women in Western Guatemala. AIDS Behav. 2018 Jul; 22(Suppl 1):45-56. View on Pubmed
  27. Brites-Alves C, Luz E, Netto EM, Ferreira T, Diaz RS, Pedroso C, Page K, Brites C. Immune Activation, Proinflammatory Cytokines, and Conventional Risks for Cardiovascular Disease in HIV Patients: A Case-Control Study in Bahia, Brazil. Front Immunol. 2018; 9:1469. View on Pubmed
  28. Duff P, Evans JL, Stein ES, Page K, Maher L. High pregnancy incidence and low contraceptive use among a prospective cohort of female entertainment and sex workers in Phnom Penh, Cambodia. BMC Pregnancy Childbirth. 2018 05 03; 18(1):128. View on Pubmed
  29. Winter SS, Page-Reeves JM, Page KA, Haozous E, Solares A, Nicole Cordova C, Larson RS. Inclusion of special populations in clinical research: important considerations and guidelines. J Clin Transl Res. 2018 May 28; 4(1):56-69. View on Pubmed
  30. Mirzazadeh A, Evans JL, Hahn JA, Jain J, Briceno A, Shiboski S, Lum PJ, Bentsen C, Davis G, Shriver K, Dimapasoc M, Stone M, Busch MP, Page K. Continued Transmission of HIV Among Young Adults Who Inject Drugs in San Francisco: Still Room for Improvement. AIDS Behav. 2018 04; 22(4):1383-1394. View on Pubmed
  31. Page K, Cox A, Lum PJ. Opioids, Hepatitis C Virus Infection, and the Missing Vaccine. Am J Public Health. 2018 02; 108(2):156-157. View on Pubmed
  32. Esmaeili A, Mirzazadeh A, Morris MD, Hajarizadeh B, Sacks HS, Maher L, Grebely J, Kim AY, Lauer G, Cox AL, Hellard M, Dietze P, Bruneau J, Shoukry NH, Dore GJ, Lloyd AR, Prins M, Page K. The Effect of Female Sex on Hepatitis C Incidence Among People Who Inject Drugs: Results From the International Multicohort InC3 Collaborative. Clin Infect Dis. 2018 01 06; 66(1):20-28. View on Pubmed
  33. Thornton K, Sedillo ML, Kalishman S, Page K, Arora S. The New Mexico Peer Education Project: Filling a Critical Gap in HCV Prison Education. J Health Care Poor Underserved. 2018; 29(4):1544-1557. View on Pubmed
  34. Morris MD, Montgomery ME, Briceno A, Evans JL, Andrew EVW, Page K, Hahn JA. A Study of Sexual Relationship Power among Young Women Who Inject Drugs and Their Sexual Partners. Subst Use Misuse. 2018 07 03; 53(8):1281-1287. View on Pubmed
  35. Muth S, Len A, Evans JL, Phou M, Chhit S, Neak Y, Ngak S, Stein ES, Carrico AW, Maher L, Page K. HIV treatment cascade among female entertainment and sex workers in Cambodia: impact of amphetamine use and an HIV prevention program. Addict Sci Clin Pract. 2017 09 05; 12(1):20. View on Pubmed
  36. Page K, Leeman L, Bishop S, Cano S, Bakhireva LN. Hepatitis C Cascade of Care Among Pregnant Women on Opioid Agonist Pharmacotherapy Attending a Comprehensive Prenatal Program. Matern Child Health J. 2017 Sep; 21(9):1778-1783. View on Pubmed
  37. Morris MD, Neilands TB, Andrew E, Maher L, Page KA, Hahn JA. Development and validation of a novel scale for measuring interpersonal factors underlying injection drug using behaviours among injecting partnerships. Int J Drug Policy. 2017 10; 48:54-62. View on Pubmed
  38. Morris MD, Shiboski S, Bruneau J, Hahn JA, Hellard M, Prins M, Cox AL, Dore G, Grebely J, Kim AY, Lauer GM, Lloyd A, Rice T, Shoukry N, Maher L, Page K. Geographic Differences in Temporal Incidence Trends of Hepatitis C Virus Infection Among People Who Inject Drugs: The InC3 Collaboration. Clin Infect Dis. 2017 Apr 01; 64(7):860-869. View on Pubmed
  39. Page K, Yu M, Cohen J, Evans J, Shumway M, Riley ED. HCV screening in a cohort of HIV infected and uninfected homeless and marginally housed women in San Francisco, California. BMC Public Health. 2017 02 07; 17(1):171. View on Pubmed
  40. Rodrigo C, Walker MR, Leung P, Eltahla AA, Grebely J, Dore GJ, Applegate T, Page K, Dwivedi S, Bruneau J, Morris MD, Cox AL, Osburn W, Kim AY, Schinkel J, Shoukry NH, Lauer GM, Maher L, Hellard M, Prins M, Luciani F, Lloyd AR, Bull RA. Limited naturally occurring escape in broadly neutralizing antibody epitopes in hepatitis C glycoprotein E2 and constrained sequence usage in acute infection. Infect Genet Evol. 2017 04; 49:88-96. View on Pubmed
  41. Page K, Bacon O. Commitment issues: PrEP adherence in injecting drug users. Lancet HIV. 2017 02; 4(2):e52-e53. View on Pubmed
  42. Tsui JI, Mirzazadeh A, Hahn JA, Maher L, Bruneau J, Grebely J, Hellard M, Kim AY, Shoukry NH, Cox AL, Prins M, Dore GJ, Lauer G, Lloyd AR, Page K. The effects of alcohol on spontaneous clearance of acute hepatitis C virus infection in females versus males. Drug Alcohol Depend. 2016 Dec 01; 169:156-162. View on Pubmed
  43. Rodrigo C, Eltahla AA, Bull RA, Grebely J, Dore GJ, Applegate T, Page K, Bruneau J, Morris MD, Cox AL, Osburn W, Kim AY, Schinkel J, Shoukry NH, Lauer GM, Maher L, Hellard M, Prins M, Estes C, Razavi H, Lloyd AR, Luciani F. Historical Trends in the Hepatitis C Virus Epidemics in North America and Australia. J Infect Dis. 2016 Nov 01; 214(9):1383-1389. View on Pubmed
  44. Asher AK, Portillo CJ, Cooper BA, Dawson-Rose C, Vlahov D, Page KA. Clinicians' Views of Hepatitis C Virus Treatment Candidacy With Direct-Acting Antiviral Regimens for People Who Inject Drugs. Subst Use Misuse. 2016 07 28; 51(9):1218-23. View on Pubmed
  45. Couture MC, Page K, Sansothy N, Stein E, Vun MC, Hahn JA. High prevalence of unhealthy alcohol use and comparison of self-reported alcohol consumption to phosphatidylethanol among women engaged in sex work and their male clients in Cambodia. Drug Alcohol Depend. 2016 Aug 01; 165:29-37. View on Pubmed
  46. Page K, Stein ES, Carrico AW, Evans JL, Sokunny M, Nil E, Ngak S, Sophal C, McCulloch C, Maher L. Protocol of a cluster randomised stepped-wedge trial of behavioural interventions targeting amphetamine-type stimulant use and sexual risk among female entertainment and sex workers in Cambodia. BMJ Open. 2016 05 09; 6(5):e010854. View on Pubmed
  47. Riley ED, Evans JL, Hahn JA, Briceno A, Davidson PJ, Lum PJ, Page K. A Longitudinal Study of Multiple Drug Use and Overdose Among Young People Who Inject Drugs. Am J Public Health. 2016 May; 106(5):915-7. View on Pubmed
  48. Crewe Dixon T, Stein E, Ngak S, Srean C, Maly P, Sokunny M, Carrico A, Page K, Maher L. Qualitative research and implementation science: Informing the acceptability and implementation of a trial of a conditional cash transfer intervention designed to reduce drug use and HIV risk. Method Innov. 2016 Jan-Feb; 9. View on Pubmed
  49. Page K, Mirzazadeh A, Rice TM, Grebely J, Kim AY, Cox AL, Morris MD, Hellard M, Bruneau J, Shoukry NH, Dore GJ, Maher L, Lloyd AR, Lauer G, Prins M, McGovern BH. Interferon Lambda 4 Genotype Is Associated With Jaundice and Elevated Aminotransferase Levels During Acute Hepatitis C Virus Infection: Findings From the InC3 Collaborative. Open Forum Infect Dis. 2016 Jan; 3(1):ofw024. View on Pubmed
  50. Draughon Moret JE, Carrico AW, Evans JL, Stein ES, Couture MC, Maher L, Page K. The impact of violence on sex risk and drug use behaviors among women engaged in sex work in Phnom Penh, Cambodia. Drug Alcohol Depend. 2016 Apr 01; 161:171-7. View on Pubmed
  51. Carrico AW, Nil E, Sophal C, Stein E, Sokunny M, Yuthea N, Evans JL, Ngak S, Maher L, Page K. Behavioral interventions for Cambodian female entertainment and sex workers who use amphetamine-type stimulants. J Behav Med. 2016 06; 39(3):502-10. View on Pubmed
  52. Dixon TC, Ngak S, Stein E, Carrico A, Page K, Maher L. Pharmacology, physiology and performance: occupational drug use and HIV risk among female entertainment and sex workers in Cambodia. Harm Reduct J. 2015 Oct 16; 12:33. View on Pubmed
  53. Morris MD, Bates A, Andrew E, Hahn J, Page K, Maher L. More than just someone to inject drugs with: Injecting within primary injection partnerships. Drug Alcohol Depend. 2015 Nov 01; 156:275-281. View on Pubmed
  54. Le Marchand C, Bahia F, Page K, Brites C. Hepatitis C virus infection and spontaneous clearance in HTLV-1 and HIV co-infected patients in Salvador, Bahia, Brazil. Braz J Infect Dis. 2015 Sep-Oct; 19(5):486-91. View on Pubmed
  55. Maher L, Page K. Reducing bias in prospective observational studies of drug users: the need for upstream and downstream approaches. Addiction. 2015 Aug; 110(8):1259-61. View on Pubmed
  56. El-Diwany R, Wasilewski LN, Witwer KW, Bailey JR, Page K, Ray SC, Cox AL, Thomas DL, Balagopal A. Acute Hepatitis C Virus Infection Induces Consistent Changes in Circulating MicroRNAs That Are Associated with Nonlytic Hepatocyte Release. J Virol. 2015 Sep; 89(18):9454-64. View on Pubmed
  57. Siddiqui SS, Armenta RF, Evans JL, Yu M, Cuevas-Mota J, Page K, Davidson P, Garfein RS. Effect of legal status of pharmacy syringe sales on syringe purchases by persons who inject drugs in San Francisco and San Diego, CA. Int J Drug Policy. 2015 Nov; 26(11):1150-7. View on Pubmed
  58. Maher L, Dixon T, Phlong P, Mooney-Somers J, Stein E, Page K. Conflicting Rights: How the Prohibition of Human Trafficking and Sexual Exploitation Infringes the Right to Health of Female Sex Workers in Phnom Penh, Cambodia. Health Hum Rights. 2015 Jun 11; 17(1):E102-13. View on Pubmed
  59. Page K, Tsui J, Maher L, Choopanya K, Vanichseni S, Mock PA, Celum C, Martin M. Biomedical HIV Prevention Including Pre-exposure Prophylaxis and Opiate Agonist Therapy for Women Who Inject Drugs: State of Research and Future Directions. J Acquir Immune Defic Syndr. 2015 Jun 01; 69 Suppl 2:S169-75. View on Pubmed
  60. Iversen J, Page K, Madden A, Maher L. HIV, HCV, and Health-Related Harms Among Women Who Inject Drugs: Implications for Prevention and Treatment. J Acquir Immune Defic Syndr. 2015 Jun 01; 69 Suppl 2:S176-81. View on Pubmed
  61. Sacks-Davis R, Grebely J, Dore GJ, Osburn W, Cox AL, Rice TM, Spelman T, Bruneau J, Prins M, Kim AY, McGovern BH, Shoukry NH, Schinkel J, Allen TM, Morris M, Hajarizadeh B, Maher L, Lloyd AR, Page K, Hellard M. Hepatitis C Virus Reinfection and Spontaneous Clearance of Reinfection--the InC3 Study. J Infect Dis. 2015 Nov 01; 212(9):1407-19. View on Pubmed
  62. Hajarizadeh B, Grady B, Page K, Kim AY, McGovern BH, Cox AL, Rice TM, Sacks-Davis R, Bruneau J, Morris M, Amin J, Schinkel J, Applegate T, Maher L, Hellard M, Lloyd AR, Prins M, Dore GJ, Grebely J. Patterns of hepatitis C virus RNA levels during acute infection: the InC3 study. PLoS One. 2015; 10(4):e0122232. View on Pubmed
  63. Wadhera P, Evans JL, Stein E, Gandhi M, Couture MC, Sansothy N, Sichan K, Maher L, Kaldor J, Page K. Human papillomavirus knowledge, vaccine acceptance, and vaccine series completion among female entertainment and sex workers in Phnom Penh, Cambodia: the Young Women's Health Study. Int J STD AIDS. 2015 Oct; 26(12):893-902. View on Pubmed
  64. Tsui JI, Evans JL, Lum PJ, Hahn JA, Page K. Association of opioid agonist therapy with lower incidence of hepatitis C virus infection in young adult injection drug users. JAMA Intern Med. 2014 Dec; 174(12):1974-81. View on Pubmed
  65. Vickerman P, Page K, Maher L, Hickman M. Commentary on Nolan et al. (2014): Opiate substitution treatment and hepatitis C virus prevention: building an evidence base? Addiction. 2014 Dec; 109(12):2060-1. View on Pubmed
  66. Morris MD, Evans J, Montgomery M, Yu M, Briceno A, Page K, Hahn JA. Intimate injection partnerships are at elevated risk of high-risk injecting: a multi-level longitudinal study of HCV-serodiscordant injection partnerships in San Francisco, CA. PLoS One. 2014; 9(10):e109282. View on Pubmed
  67. Hajarizadeh B, Grady B, Page K, Kim AY, McGovern BH, Cox AL, Rice TM, Sacks-Davis R, Bruneau J, Morris M, Amin J, Schinkel J, Applegate T, Maher L, Hellard M, Lloyd AR, Prins M, Geskus RB, Dore GJ, Grebely J. Interferon lambda 3 genotype predicts hepatitis C virus RNA levels in early acute infection among people who inject drugs: the InC(3) study. J Clin Virol. 2014 Nov; 61(3):430-4. View on Pubmed
  68. White B, Madden A, Prins M, Hellard M, Wand H, Dore GJ, Page K, Maher L. Assessing the feasibility of hepatitis C virus vaccine trials: results from the Hepatitis C Incidence and Transmission Study-community (HITS-c) vaccine preparedness study. Vaccine. 2014 Sep 22; 32(42):5460-7. View on Pubmed
  69. Evans JL, Morris MD, Yu M, Page K, Hahn JA. Concordance of risk behavior reporting within HCV serodiscordant injecting partnerships of young injection drug users in San Francisco, CA. Drug Alcohol Depend. 2014 Sep 01; 142:239-44. View on Pubmed
  70. Hayes B, Briceno A, Asher A, Yu M, Evans JL, Hahn JA, Page K. Preference, acceptability and implications of the rapid hepatitis C screening test among high-risk young people who inject drugs. BMC Public Health. 2014 Jun 25; 14:645. View on Pubmed
  71. Jain J, Evans JL, Briceño A, Page K, Hahn JA. Comparison of phosphatidylethanol results to self-reported alcohol consumption among young injection drug users. Alcohol Alcohol. 2014 Sep-Oct; 49(5):520-4. View on Pubmed
  72. Tracy D, Hahn JA, Fuller Lewis C, Evans J, Briceño A, Morris MD, Lum PJ, Page K. Higher risk of incident hepatitis C virus among young women who inject drugs compared with young men in association with sexual relationships: a prospective analysis from the UFO Study cohort. BMJ Open. 2014 May 29; 4(5):e004988. View on Pubmed
  73. Grebely J, Dore GJ, Kim AY, Lloyd A, Shoukry NH, Prins M, Page K. Genetics of spontaneous clearance of hepatitis C virus infection: a complex topic with much to learn. Hepatology. 2014 Dec; 60(6):2127-8. View on Pubmed
  74. Grebely J, Grady B, Hajarizadeh B, Page K, Dore GJ. Disease progression during advanced fibrosis: IL28B genotype or HCV RNA levels? Hepatology. 2014 Apr; 59(4):1650-1. View on Pubmed
  75. Dokubo EK, Evans J, Winkelman V, Cyrus S, Tobler LH, Asher A, Briceno A, Page K. Comparison of Hepatitis C Virus RNA and antibody detection in dried blood spots and plasma specimens. J Clin Virol. 2014 Apr; 59(4):223-7. View on Pubmed
  76. Miranda AE, Pinto VM, McFarland W, Page K. HIV infection among young pregnant women in Brazil: prevalence and associated risk factors. AIDS Behav. 2014 Jan; 18 Suppl 1:S50-2. View on Pubmed
  77. Ikeda JM, Tellez CA, Hudes ES, Page K, Evans J, Racancoj O, Hearst N. Impact of integrating HIV and TB care and treatment in a regional tuberculosis hospital in rural Guatemala. AIDS Behav. 2014 Jan; 18 Suppl 1:S96-103. View on Pubmed
  78. Silveira MP, Guttier MC, Moreira LB, Mirzazadeh A, Page K. Predictors of non-adherence to clinical follow-up among patients participating in a randomized trial of pharmaceutical care intervention in HIV-positive adults in Southern Brazil. AIDS Behav. 2014 Jan; 18 Suppl 1:S85-8. View on Pubmed
  79. Silveira MP, Guttier MC, Page K, Moreira LB. Randomized controlled trial to evaluate the impact of pharmaceutical care on therapeutic success in HIV-infected patients in Southern Brazil. AIDS Behav. 2014 Jan; 18 Suppl 1:S75-84. View on Pubmed
  80. Ikeda JM, Schaffer JR, Sac Ixcot ML, Page K, Hearst N. Risk of sexually transmitted infections among Mayan women in rural Guatemala whose partners are migrant workers. AIDS Behav. 2014 Jan; 18 Suppl 1:S32-6. View on Pubmed
  81. Callegari FM, Pinto-Neto LF, Medeiros CJ, Scopel CB, Page K, Miranda AE. Syphilis and HIV co-infection in patients who attend an AIDS outpatient clinic in Vitoria, Brazil. AIDS Behav. 2014 Jan; 18 Suppl 1:S104-9. View on Pubmed
  82. Inglez-Dias A, Ribeiro JM, Bastos FI, Page K. [Harm reduction policies in Brazil: contributions of a North American program]. Cien Saude Colet. 2014 Jan; 19(1):147-57. View on Pubmed
  83. Grebely J, Page K, Sacks-Davis R, van der Loeff MS, Rice TM, Bruneau J, Morris MD, Hajarizadeh B, Amin J, Cox AL, Kim AY, McGovern BH, Schinkel J, George J, Shoukry NH, Lauer GM, Maher L, Lloyd AR, Hellard M, Dore GJ, Prins M. The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection. Hepatology. 2014 Jan; 59(1):109-20. View on Pubmed
  84. Asher AK, Santos GM, Evans J, Dokubo EK, Lee TH, Martin JN, Deeks SG, Tobler LH, Busch M, Hunt PW, Page K. Human leukocyte antigen B*57 does not fully explain hepatitis C clearance in HIV controllers. AIDS. 2013 Nov 13; 27(17):2691-6. View on Pubmed
  85. Kim AY, Page K. Hepatitis C virus serosorting in people who inject drugs: sorting out the details. J Infect Dis. 2013 Dec 15; 208(12):1929-31. View on Pubmed
  86. Page K, Stein E, Sansothy N, Evans J, Couture MC, Sichan K, Cockroft M, Mooney-Somers J, Phlong P, Kaldor J, Maher L. Sex work and HIV in Cambodia: trajectories of risk and disease in two cohorts of high-risk young women in Phnom Penh, Cambodia. BMJ Open. 2013 Sep 10; 3(9):e003095. View on Pubmed
  87. Briceño A, Morris MD, Evans J, Raymond HF, Page K. Characteristics and health service utilization in two samples of young injection drug users recruited using direct and referral methods in San Francisco, California. J Alcohol Drug Depend. 2013 Aug; 1(5). View on Pubmed
  88. Page K, Morris MD, Hahn JA, Maher L, Prins M. Injection drug use and hepatitis C virus infection in young adult injectors: using evidence to inform comprehensive prevention. Clin Infect Dis. 2013 Aug; 57 Suppl 2:S32-8. View on Pubmed
  89. Page K, Morris MD, Hahn JA, Maher L, Prins M. Clinical Infectious Diseases. Injection drug use and hepatitis C virus infection in young adult injectors: using evidence to inform comprehensive prevention. 2013; S2(57):32-38. View on Pubmed
  90. Pinto Neto LF, das Neves MB, Ribeiro-Rodrigues R, Page K, Miranda AE. Dyslipidemia and fasting glucose impairment among HIV patients three years after the first antiretroviral regimen in a Brazilian AIDS outpatient clinic. Braz J Infect Dis. 2013 Jul-Aug; 17(4):438-43. View on Pubmed
  91. Evans JL, Couture MC, Stein ES, Sansothy N, Maher L, Page K. Biomarker validation of recent unprotected sexual intercourse in a prospective study of young women engaged in sex work in Phnom Penh, Cambodia. Sex Transm Dis. 2013 Jun; 40(6):462-8. View on Pubmed
  92. Montgomery ME, Fatch RS, Evans JL, Yu M, Davidson PJ, Page K, Hahn JA. Injecting risk behavior among traveling young injection drug users: travel partner and city characteristics. J Urban Health. 2013 Jun; 90(3):500-15. View on Pubmed
  93. Blatyta PF, Custer B, Gonçalez TT, Birch R, Lopes ME, Lopes Ferreira MI, Carneiro Proietti AB, Sabino EC, Page K, de Almeida-Neto C. Undisclosed human immunodeficiency virus risk factors identified through a computer-based questionnaire program among blood donors in Brazil. Transfusion. 2013 Nov; 53(11):2734-43. View on Pubmed
  94. Maher L, Mooney-Somers J, Phlong P, Couture MC, Kien SP, Stein E, Bates AJ, Sansothy N, Page K. Condom negotiation across different relationship types by young women engaged in sex work in Phnom Penh, Cambodia. Glob Public Health. 2013; 8(3):270-83. View on Pubmed
  95. Etcheverry MF, Evans JL, Sanchez E, Mendez-Arancibia E, Meroño M, Gatell JM, Page K, Joseph J. Enhanced retention strategies and willingness to participate among hard-to-reach female sex workers in Barcelona for HIV prevention and vaccine trials. Hum Vaccin Immunother. 2013 Feb; 9(2):420-9. View on Pubmed
  96. Grebely J, Morris MD, Rice TM, Bruneau J, Cox AL, Kim AY, McGovern BH, Shoukry NH, Lauer G, Maher L, Lloyd AR, Hellard M, Prins M, Dore GJ, Page K. Cohort profile: the international collaboration of incident HIV and hepatitis C in injecting cohorts (InC3) study. Int J Epidemiol. 2013 Dec; 42(6):1649-59. View on Pubmed
  97. Asher AK, Hahn JA, Couture MC, Maher K, Page K. people who inject drugs, HIV risk, and HIV testing uptake in sub-Saharan Africa. J Assoc Nurses AIDS Care. 2013 Nov-Dec; 24(6):e35-44. View on Pubmed
  98. White B, Madden A, Hellard M, Kerr T, Prins M, Page K, Dore GJ, Maher L. Increased hepatitis C virus vaccine clinical trial literacy following a brief intervention among people who inject drugs. Drug Alcohol Rev. 2013 Jul; 32(4):419-25. View on Pubmed
  99. Page K, Osburn W, Evans J, Hahn JA, Lum P, Asher A, Delwart E, Tobler L, Cox AL, Busch MP. Frequent longitudinal sampling of hepatitis C virus infection in injection drug users reveals intermittently detectable viremia and reinfection. Clin Infect Dis. 2013 Feb; 56(3):405-13. View on Pubmed
  100. Brown C, Krishnan S, Hursh K, Yu M, Johnson P, Page K, Shiboski CH. Dental disease prevalence among methamphetamine and heroin users in an urban setting: a pilot study. J Am Dent Assoc. 2012 Sep; 143(9):992-1001. View on Pubmed
  101. Couture MC, Page K, Stein ES, Sansothy N, Sichan K, Kaldor J, Evans JL, Maher L, Palefsky J. Cervical human papillomavirus infection among young women engaged in sex work in Phnom Penh, Cambodia: prevalence, genotypes, risk factors and association with HIV infection. BMC Infect Dis. 2012 Jul 28; 12:166. View on Pubmed
  102. Wang Z, Du J, Zhao M, Page K, Xiao Z, Mandel JS. Hepatitis C virus infection is independently associated with depression among methadone maintenance treatment heroin users in China. Asia Pac Psychiatry. 2013 Sep; 5(3):191-6. View on Pubmed
  103. Le Marchand C, Evans J, Page K, Davidson PJ, Hahn JA. Hazardous alcohol consumption among young adult IDU and its association with high risk behaviors. Drug Alcohol Depend. 2013 Jan 01; 127(1-3):143-9. View on Pubmed
  104. Kab V, Evans J, Sansothy N, Stein E, Claude-Couture M, Maher L, Page K. Testing for amphetamine-type stimulant (ATS) use to ascertain validity of self-reported ATS use among young female sex workers in Cambodia. Addict Sci Clin Pract. 2012 Jun 28; 7:11. View on Pubmed
  105. Davidson P, Page K. Research participation as work: comparing the perspectives of researchers and economically marginalized populations. Am J Public Health. 2012 Jul; 102(7):1254-9. View on Pubmed
  106. Grebely J, Prins M, Hellard M, Cox AL, Osburn WO, Lauer G, Page K, Lloyd AR, Dore GJ. Hepatitis C virus clearance, reinfection, and persistence, with insights from studies of injecting drug users: towards a vaccine. Lancet Infect Dis. 2012 May; 12(5):408-14. View on Pubmed
  107. Vickerman P, Grebely J, Dore GJ, Sacks-Davis R, Page K, Thomas DL, Osburn WO, Cox AL, Aitken CK, Hickman M, Hellard M. The more you look, the more you find: effects of hepatitis C virus testing interval on reinfection incidence and clearance and implications for future vaccine study design. J Infect Dis. 2012 May 01; 205(9):1342-50. View on Pubmed
  108. Evans JL, Tsui JI, Hahn JA, Davidson PJ, Lum PJ, Page K. Mortality among young injection drug users in San Francisco: a 10-year follow-up of the UFO study. Am J Epidemiol. 2012 Feb 15; 175(4):302-8. View on Pubmed
  109. Miranda AE, Figueiredo NC, Pinto VM, Page K, Talhari S. Risk factors for syphilis in young women attending a family health program in Vitória, Brazil. An Bras Dermatol. 2012 Jan-Feb; 87(1):76-83. View on Pubmed
  110. Maher L, Mooney-Somers J, Phlong P, Couture MC, Stein E, Evans J, Cockroft M, Sansothy N, Nemoto T, Page K. Selling sex in unsafe spaces: sex work risk environments in Phnom Penh, Cambodia. Harm Reduct J. 2011 Nov 20; 8:30. View on Pubmed
  111. Pinho AA, Chinaglia M, Lippman SA, Reingold A, Diaz RS, Sucupira MC, Page K, Díaz J. Prevalence and factors associated with HSV-2 and hepatitis B infections among truck drivers crossing the southern Brazilian border. Sex Transm Infect. 2011 Dec; 87(7):553-9. View on Pubmed
  112. Singh KM, Phung YT, Kohla MS, Lan BY, Chan S, Suen DL, Murad S, Rheault S, Davidson P, Evans J, Singh M, Dohil S, Osorio RW, Wakil AE, Page K, Feng S, Cooper SL. KIR genotypic diversity can track ancestries in heterogeneous populations: a potential confounder for disease association studies. Immunogenetics. 2012 Feb; 64(2):97-109. View on Pubmed
  113. Couture MC, Evans JL, Sothy NS, Stein ES, Sichan K, Maher L, Page K. Correlates of amphetamine-type stimulant use and associations with HIV-related risks among young women engaged in sex work in Phnom Penh, Cambodia. Drug Alcohol Depend. 2012 Jan 01; 120(1-3):119-26. View on Pubmed
  114. Dias PT, Hahn JA, Delwart E, Edlin B, Martin J, Lum P, Evans J, Kral A, Deeks S, Busch MP, Page K. Temporal changes in HCV genotype distribution in three different high risk populations in San Francisco, California. BMC Infect Dis. 2011 Aug 02; 11:208. View on Pubmed
  115. Bahia F, Novais V, Evans J, Le Marchand C, Netto E, Page K, Brites C. The impact of human T-cell lymphotropic virus I infection on clinical and immunologic outcomes in patients coinfected with HIV and hepatitis C virus. J Acquir Immune Defic Syndr. 2011 Aug; 57 Suppl 3:S202-7. View on Pubmed
  116. Asher A, Lum PJ, Page K. Assessing candidacy for acute hepatitis C treatment among active young injection drug users: a case-series report. J Assoc Nurses AIDS Care. 2012 Jan-Feb; 23(1):16-29. View on Pubmed
  117. Maher L, Phlong P, Mooney-Somers J, Keo S, Stein E, Couture MC, Page K. Amphetamine-type stimulant use and HIV/STI risk behaviour among young female sex workers in Phnom Penh, Cambodia. Int J Drug Policy. 2011 May; 22(3):203-9. View on Pubmed
  118. Etcheverry MF, Lum PJ, Evans JL, Sanchez E, de Lazzari E, Mendez-Arancibia E, Sierra E, Gatell JM, Page K, Joseph J. HIV vaccine trial willingness among injection and non-injection drug users in two urban centres, Barcelona and San Francisco. Vaccine. 2011 Feb 24; 29(10):1991-6. View on Pubmed
  119. Couture MC, Sansothy N, Sapphon V, Phal S, Sichan K, Stein E, Evans J, Maher L, Kaldor J, Vun MC, Page K. Young women engaged in sex work in Phnom Penh, Cambodia, have high incidence of HIV and sexually transmitted infections, and amphetamine-type stimulant use: new challenges to HIV prevention and risk. Sex Transm Dis. 2011 Jan; 38(1):33-9. View on Pubmed
  120. Maher L, White B, Hellard M, Madden A, Prins M, Kerr T, Page K. Candidate hepatitis C vaccine trials and people who inject drugs: challenges and opportunities. Vaccine. 2010 Oct 21; 28(45):7273-8. View on Pubmed
  121. Levy V, Evans JL, Stein ES, Davidson PJ, Lum PJ, Hahn JA, Page K. Are young injection drug users ready and willing to participate in preventive HCV vaccine trials? Vaccine. 2010 Aug 23; 28(37):5947-51. View on Pubmed
  122. Hahn JA, Evans JL, Davidson PJ, Lum PJ, Page K. Hepatitis C virus risk behaviors within the partnerships of young injecting drug users. Addiction. 2010 Jul; 105(7):1254-64. View on Pubmed
  123. Berini CA, Gendler SA, Pascuccio S, Eirin ME, McFarland W, Page K, Carnevali L, Murphy E, Biglione MM. Decreasing trends in HTLV-1/2 but stable HIV-1 infection among replacement donors in Argentina. J Med Virol. 2010 May; 82(5):873-7. View on Pubmed
  124. Sarang A, Rhodes T, Sheon N, Page K. Policing drug users in Russia: risk, fear, and structural violence. Subst Use Misuse. 2010 May; 45(6):813-64. View on Pubmed
  125. Page K, Hahn JA, Evans J, Shiboski S, Lum P, Delwart E, Tobler L, Andrews W, Avanesyan L, Cooper S, Busch MP. Acute hepatitis C virus infection in young adult injection drug users: a prospective study of incident infection, resolution, and reinfection. J Infect Dis. 2009 Oct 15; 200(8):1216-26. View on Pubmed
  126. Miranda AE, St Louis ME, Figueiredo NC, Milbratz I, Page-Shafer K. Young women and their reproductive health needs in a family practice setting: factors influencing care seeking in Vitoria, Brazil. Fam Pract. 2009 Dec; 26(6):493-500. View on Pubmed
  127. Tsui JI, Vittinghoff E, Hahn JA, Evans JL, Davidson PJ, Page K. Risk behaviors after hepatitis C virus seroconversion in young injection drug users in San Francisco. Drug Alcohol Depend. 2009 Nov 01; 105(1-2):160-3. View on Pubmed
  128. Levy V, Yuan J, Ruiz J, Morrow S, Reardon J, Facer M, Molitor F, Allen B, Ajufo BG, Bell-Sanford G, McFarland W, Raymond HF, Kellogg T, Page K. Hepatitis B sero-prevalence and risk behaviors among immigrant men in a population-based household survey in low-income neighborhoods of northern California. J Immigr Minor Health. 2010 Dec; 12(6):828-33. View on Pubmed
  129. Hahn JA, Wylie D, Dill J, Sanchez MS, Lloyd-Smith JO, Page-Shafer K, Getz WM. Potential impact of vaccination on the hepatitis C virus epidemic in injection drug users. Epidemics. 2009 Mar; 1(1):47-57. View on Pubmed
  130. Evans JL, Hahn JA, Lum PJ, Stein ES, Page K. Predictors of injection drug use cessation and relapse in a prospective cohort of young injection drug users in San Francisco, CA (UFO Study). Drug Alcohol Depend. 2009 May 01; 101(3):152-7. View on Pubmed
  131. Cox AL, Page K, Bruneau J, Shoukry NH, Lauer GM, Kim AY, Rosen HR, Radziewicz H, Grakoui A, Fierer DS, Branch AD, Kaplan DE, Chang KM. Rare birds in North America: acute hepatitis C cohorts. Gastroenterology. 2009 Jan; 136(1):26-31. View on Pubmed
  132. Figueiredo NC, Page-Shafer K, Pereira FE, Miranda AE. [Serological markers for hepatitis B virus in young women attended by the Family Health Program in Vitória, Espírito Santo, 2006]. Rev Soc Bras Med Trop. 2008 Nov-Dec; 41(6):590-5. View on Pubmed
  133. Sampaio-Sa M, Page-Shafer K, Bangsberg DR, Evans J, Dourado Mde L, Teixeira C, Netto EM, Brites C. 100% adherence study: educational workshops vs. video sessions to improve adherence among ART-naïve patients in Salvador, Brazil. AIDS Behav. 2008 Jul; 12(4 Suppl):S54-62. View on Pubmed
  134. Fialho M, Messias M, Page-Shafer K, Farre L, Schmalb M, Pedral-Sampaio D, Ramos M, Brites C. Prevalence and risk of blood-borne and sexually transmitted viral infections in incarcerated youth in Salvador, Brazil: opportunity and obligation for intervention. AIDS Behav. 2008 Jul; 12(4 Suppl):S17-24. View on Pubmed
  135. Inglez-Dias A, Hahn JA, Lum PJ, Evans J, Davidson P, Page-Shafer K. Trends in methamphetamine use in young injection drug users in San Francisco from 1998 to 2004: the UFO Study. Drug Alcohol Rev. 2008 May; 27(3):286-91. View on Pubmed
  136. Miranda AE, Figueiredo NC, Schmidt R, Page-Shafer K. A population-based survey of the prevalence of HIV, syphilis, hepatitis B and hepatitis C infections, and associated risk factors among young women in Vitória, Brazil. AIDS Behav. 2008 Jul; 12(4 Suppl):S25-31. View on Pubmed
  137. Lum PJ, Hahn JA, Shafer KP, Evans JL, Davidson PJ, Stein E, Moss AR. Hepatitis B virus infection and immunization status in a new generation of injection drug users in San Francisco. J Viral Hepat. 2008 Mar; 15(3):229-36. View on Pubmed
  138. Hunt PW, Brenchley J, Sinclair E, McCune JM, Roland M, Page-Shafer K, Hsue P, Emu B, Krone M, Lampiris H, Douek D, Martin JN, Deeks SG. Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy. J Infect Dis. 2008 Jan 01; 197(1):126-33. View on Pubmed
  139. Page-Shafer K, Pappalardo BL, Tobler LH, Phelps BH, Edlin BR, Moss AR, Wright TL, Wright DJ, O'Brien TR, Caglioti S, Busch MP. Testing strategy to identify cases of acute hepatitis C virus (HCV) infection and to project HCV incidence rates. J Clin Microbiol. 2008 Feb; 46(2):499-506. View on Pubmed
  140. Hahn JA, Page-Shafer K, Ford J, Paciorek A, Lum PJ. Traveling young injection drug users at high risk for acquisition and transmission of viral infections. Drug Alcohol Depend. 2008 Jan 11; 93(1-2):43-50. View on Pubmed
  141. Page-Shafer K, Hahn JA, Lum PJ. Preventing hepatitis C virus infection in injection drug users: risk reduction is not enough. AIDS. 2007 Sep 12; 21(14):1967-9. View on Pubmed
  142. Bernardin F, Stramer SL, Rehermann B, Page-Shafer K, Cooper S, Bangsberg DR, Hahn J, Tobler L, Busch M, Delwart E. High levels of subgenomic HCV plasma RNA in immunosilent infections. Virology. 2007 Sep 01; 365(2):446-56. View on Pubmed
  143. Sucupira MC, Caseiro MM, Alves K, Tescarollo G, Janini LM, Sabino EC, Castelo A, Page-Shafer K, Diaz RS. High levels of primary antiretroviral resistance genotypic mutations and B/F recombinants in Santos, Brazil. AIDS Patient Care STDS. 2007 Feb; 21(2):116-28. View on Pubmed
  144. Levy V, Prentiss D, Balmas G, Chen S, Israelski D, Katzenstein D, Page-Shafer K. Factors in the delayed HIV presentation of immigrants in Northern California: implications for voluntary counseling and testing programs. J Immigr Minor Health. 2007 Jan; 9(1):49-54. View on Pubmed
  145. Bernardin F, Herring B, Page-Shafer K, Kuiken C, Delwart E. Absence of HCV viral recombination following superinfection. J Viral Hepat. 2006 Aug; 13(8):532-7. View on Pubmed
  146. de Carvalho FT, Neiva-Silva L, Ramos MC, Evans J, Koller SH, Piccinini CA, Page-Shafer K. Sexual and drug use risk behaviors among children and youth in street circumstances in Porto Alegre, Brazil. AIDS Behav. 2006 Jul; 10(4 Suppl):S57-66. View on Pubmed
  147. Telles Dias PR, Souto K, Page-Shafer K. Long-term female condom use among vulnerable populations in Brazil. AIDS Behav. 2006 Jul; 10(4 Suppl):S67-75. View on Pubmed
  148. Page-Shafer K, Sweet S, Kassaye S, Ssali C. (C2) Saliva, breast milk, and mucosal fluids in HIV transmission. Adv Dent Res. 2006 Apr 01; 19(1):152-7. View on Pubmed
  149. Bacon O, Lum P, Hahn J, Evans J, Davidson P, Moss A, Page-Shafer K. Commercial sex work and risk of HIV infection among young drug-injecting men who have sex with men in San Francisco. Sex Transm Dis. 2006 Apr; 33(4):228-34. View on Pubmed
  150. Kim AA, Sun LP, Chhorvann C, Lindan C, Van Griensven F, Kilmarx PH, Sirivongrangson P, Louie JK, Leng HB, Page-Shafer K. High prevalence of HIV and sexually transmitted infections among indirect sex workers in Cambodia. Sex Transm Dis. 2005 Dec; 32(12):745-51. View on Pubmed
  151. Cohan DL, Kim A, Ruiz J, Morrow S, Reardon J, Lynch M, Klausner JD, Molitor F, Allen B, Green Ajufo B, Ferrero D, Bell Sanford G, Page-Shafer K, Delgado V, McFarland W. Health indicators among low income women who report a history of sex work: the population based Northern California Young Women's Survey. Sex Transm Infect. 2005 Oct; 81(5):428-33. View on Pubmed
  152. Page-Shafer K, Saphonn V, Sun LP, Vun MC, Cooper DA, Kaldor JM. HIV prevention research in a resource-limited setting: the experience of planning a trial in Cambodia. Lancet. 2005 Oct 22-28; 366(9495):1499-503. View on Pubmed
  153. Levy V, Page-Shafer K, Evans J, Ruiz J, Morrow S, Reardon J, Lynch M, Raymond HF, Klausner JD, Facer M, Molitor F, Allen B, Ajufo BG, Ferrero D, Sanford GB, McFarland W. HIV-related risk behavior among Hispanic immigrant men in a population-based household survey in low-income neighborhoods of northern California. Sex Transm Dis. 2005 Aug; 32(8):487-90. View on Pubmed
  154. Ochoa KC, Davidson PJ, Evans JL, Hahn JA, Page-Shafer K, Moss AR. Heroin overdose among young injection drug users in San Francisco. Drug Alcohol Depend. 2005 Dec 12; 80(3):297-302. View on Pubmed
  155. Fox RK, Currie SL, Evans J, Wright TL, Tobler L, Phelps B, Busch MP, Page-Shafer KA. Hepatitis C virus infection among prisoners in the California state correctional system. Clin Infect Dis. 2005 Jul 15; 41(2):177-86. View on Pubmed
  156. Busch MP, Shafer KA. Acute-phase hepatitis C virus infection: implications for research, diagnosis, and treatment. Clin Infect Dis. 2005 Apr 01; 40(7):959-61. View on Pubmed
  157. Kral AH, Page-Shafer K, Edlin BR, Kellogg T, Riley E, Gee L, Moss A, Busch M, Klausner JD, Dilley J, McFarland W. Persistent HIV incidence among injection drug users in San Francisco during the 1990s: results of five studies. J Acquir Immune Defic Syndr. 2004 Dec 15; 37(5):1667-9. View on Pubmed
  158. Herring BL, Page-Shafer K, Tobler LH, Delwart EL. Frequent hepatitis C virus superinfection in injection drug users. J Infect Dis. 2004 Oct 15; 190(8):1396-403. View on Pubmed
  159. Miranda AE, Szwarcwald CL, Peres RL, Page-Shafer K. Prevalence and risk behaviors for chlamydial infection in a population-based study of female adolescents in Brazil. Sex Transm Dis. 2004 Sep; 31(9):542-6. View on Pubmed
  160. Samnang P, Leng HB, Kim A, Canchola A, Moss A, Mandel JS, Page-Shafer K. HIV prevalence and risk factors among fishermen in Sihanouk Ville, Cambodia. Int J STD AIDS. 2004 Jul; 15(7):479-83. View on Pubmed
  161. Karlsson RK, Jennes W, Page-Shafer K, Nixon DF, Shacklett BL. Poorly soluble peptides can mimic authentic ELISPOT responses. J Immunol Methods. 2004 Feb 01; 285(1):89-92. View on Pubmed
  162. Porco TC, Martin JN, Page-Shafer KA, Cheng A, Charlebois E, Grant RM, Osmond DH. Decline in HIV infectivity following the introduction of highly active antiretroviral therapy. AIDS. 2004 Jan 02; 18(1):81-8. View on Pubmed
  163. Hammer GP, Kellogg TA, McFarland WC, Wong E, Louie B, Williams I, Dilley J, Page-Shafer K, Klausner JD. Low incidence and prevalence of hepatitis C virus infection among sexually active non-intravenous drug-using adults, San Francisco, 1997-2000. Sex Transm Dis. 2003 Dec; 30(12):919-24. View on Pubmed
  164. Lum PJ, Ochoa KC, Hahn JA, Page Shafer K, Evans JL, Moss AR. Hepatitis B virus immunization among young injection drug users in San Francisco, Calif: the UFO Study. Am J Public Health. 2003 Jun; 93(6):919-23. View on Pubmed
  165. Turner KR, McFarland W, Kellogg TA, Wong E, Page-Shafer K, Louie B, Dilley J, Kent CK, Klausner J. Incidence and prevalence of herpes simplex virus type 2 infection in persons seeking repeat HIV counseling and testing. Sex Transm Dis. 2003 Apr; 30(4):331-4. View on Pubmed
  166. Evans JL, Hahn JA, Page-Shafer K, Lum PJ, Stein ES, Davidson PJ, Moss AR. Gender differences in sexual and injection risk behavior among active young injection drug users in San Francisco (the UFO Study). J Urban Health. 2003 Mar; 80(1):137-46. View on Pubmed
  167. Buavirat A, Page-Shafer K, van Griensven GJ, Mandel JS, Evans J, Chuaratanaphong J, Chiamwongpat S, Sacks R, Moss A. Risk of prevalent HIV infection associated with incarceration among injecting drug users in Bangkok, Thailand: case-control study. BMJ. 2003 Feb 08; 326(7384):308. View on Pubmed
  168. Page-Shafer K, Shiboski CH, Osmond DH, Dilley J, McFarland W, Shiboski SC, Klausner JD, Balls J, Greenspan D, Greenspan JS. Risk of HIV infection attributable to oral sex among men who have sex with men and in the population of men who have sex with men. AIDS. 2002 Nov 22; 16(17):2350-2. View on Pubmed
  169. Hahn JA, Page-Shafer K, Lum PJ, Bourgois P, Stein E, Evans JL, Busch MP, Tobler LH, Phelps B, Moss AR. Hepatitis C virus seroconversion among young injection drug users: relationships and risks. J Infect Dis. 2002 Dec 01; 186(11):1558-64. View on Pubmed
  170. Fernyak SE, Page-Shafer K, Kellogg TA, McFarland W, Katz MH. Risk behaviors and HIV incidence among repeat testers at publicly funded HIV testing sites in San Francisco. J Acquir Immune Defic Syndr. 2002 Sep 01; 31(1):63-70. View on Pubmed
  171. Scheer S, Peterson I, Page-Shafer K, Delgado V, Gleghorn A, Ruiz J, Molitor F, McFarland W, Klausner J. Sexual and drug use behavior among women who have sex with both women and men: results of a population-based survey. Am J Public Health. 2002 Jul; 92(7):1110-2. View on Pubmed
  172. Page-Shafer KA, Cahoon-Young B, Klausner JD, Morrow S, Molitor F, Ruiz J, McFarland W. Hepatitis C virus infection in young, low-income women: the role of sexually transmitted infection as a potential cofactor for HCV infection. Am J Public Health. 2002 Apr; 92(4):670-6. View on Pubmed
  173. Shugars DC, Sweet SP, Malamud D, Kazmi SH, Page-Shafer K, Challacombe SJ. Saliva and inhibition of HIV-1 infection: molecular mechanisms. Oral Dis. 2002; 8 Suppl 2:169-75. View on Pubmed
  174. McCarthy GM, Ssali CS, Bednarsh H, Jorge J, Wangrangsimakul K, Page-Shafer K. Transmission of HIV in the dental clinic and elsewhere. Oral Dis. 2002; 8 Suppl 2:126-35. View on Pubmed
  175. Page-Shafer K, Graves A, Kent C, Balls JE, Zapitz VM, Klausner JD. Increased sensitivity of DNA amplification testing for the detection of pharyngeal gonorrhea in men who have sex with men. Clin Infect Dis. 2002 Jan 15; 34(2):173-6. View on Pubmed
  176. Turner J, Page-Shafer K, Chin DP, Osmond D, Mossar M, Markstein L, Huitsing J, Barnes S, Clemente V, Chesney M. Adverse impact of cigarette smoking on dimensions of health-related quality of life in persons with HIV infection. AIDS Patient Care STDS. 2001 Dec; 15(12):615-24. View on Pubmed
  177. Moon MW, Binson D, Page-Shafer K, Díaz R. Correlates of HIV risk in a random sample of street youths in San Francisco. J Assoc Nurses AIDS Care. 2001 Nov-Dec; 12(6):18-27. View on Pubmed
  178. Hahn JA, Page-Shafer K, Lum PJ, Ochoa K, Moss AR. Hepatitis C virus infection and needle exchange use among young injection drug users in San Francisco. Hepatology. 2001 Jul; 34(1):180-7. View on Pubmed
  179. Misegades L, Page-Shafer K, Halperin D, McFarland W. Anal intercourse among young low-income women in California: an overlooked risk factor for HIV? AIDS. 2001 Mar 09; 15(4):534-5. View on Pubmed
  180. Greenwood GL, White EW, Page-Shafer K, Bein E, Osmond DH, Paul J, Stall RD. Correlates of heavy substance use among young gay and bisexual men: The San Francisco Young Men's Health Study. Drug Alcohol Depend. 2001 Jan 01; 61(2):105-12. View on Pubmed
  181. Rugg DL, Heitgerd JL, Cotton DA, Broyles S, Freeman A, Lopez-Gomez AM, Cotten-Oldenburg NU, Page-Shafer K. CDC HIV prevention indicators: monitoring and evaluating HIV prevention in the USA. AIDS. 2000 Sep 08; 14(13):2003-13. View on Pubmed
  182. Page-Shafer K, Kim A, Norton P, Rugg D, Heitgerd J, Katz MH, McFarland W. Evaluating national HIV prevention indicators: a case study in San Francisco. AIDS. 2000 Sep 08; 14(13):2015-26. View on Pubmed
  183. Buchacz K, McFarland W, Hernandez M, Klausner JD, Page-Shafer K, Padian N, Molitor F, Ruiz JD, Bolan G, Morrow S, Katz MH. Prevalence and correlates of herpes simplex virus type 2 infection in a population-based survey of young women in low-income neighborhoods of Northern California. The Young Women's Survey Team. Sex Transm Dis. 2000 Aug; 27(7):393-400. View on Pubmed
  184. Ruiz JD, Molitor F, McFarland W, Klausner J, Lemp G, Page-Shafer K, Parikh-Patel A, Morrow S, Sun RK. Prevalence of HIV infection, sexually transmitted diseases, and hepatitis and related risk behavior in young women living in low-income neighborhoods of northern California. West J Med. 2000 Jun; 172(6):368-73. View on Pubmed
  185. Martin JN, Amad Z, Cossen C, Lam PK, Kedes DH, Page-Shafer KA, Osmond DH, Forghani B. Use of epidemiologically well-defined subjects and existing immunofluorescence assays to calibrate a new enzyme immunoassay for human herpesvirus 8 antibodies. J Clin Microbiol. 2000 Feb; 38(2):696-701. View on Pubmed
  186. Martin JN, Ganem DE, Osmond DH, Page-Shafer KA, Macrae D, Kedes DH. Sexual transmission and the natural history of human herpesvirus 8 infection. N Engl J Med. 1998 Apr 02; 338(14):948-54. View on Pubmed
  187. Page-Shafer K, Veugelers PJ, Moss AR, Strathdee S, Kaldor JM, van Griensven GJ. Sexual risk behavior and risk factors for HIV-1 seroconversion in homosexual men participating in the Tricontinental Seroconverter Study, 1982-1994. Am J Epidemiol. 1997 Oct 01; 146(7):531-42. View on Pubmed
  188. Veugelers PJ, Kaldor JM, Strathdee SA, Page-Shafer KA, Schechter MT, Coutinho RA, Keet IP, van Griensven GJ. Incidence and prognostic significance of symptomatic primary human immunodeficiency virus type 1 infection in homosexual men. J Infect Dis. 1997 Jul; 176(1):112-7. View on Pubmed
  189. Page-Shafer K, Delorenze GN, Satariano WA, Winkelstein W. Comorbidity and survival in HIV-infected men in the San Francisco Men's Health Survey. Ann Epidemiol. 1996 Sep; 6(5):420-30. View on Pubmed
  190. Strathdee SA, Veugelers PJ, Page-Shafer KA, McNulty A, Moss AR, Schechter MT, van Griensven GJ, Coutinho RA. Lack of consistency between five definitions of nonprogression in cohorts of HIV-infected seroconverters. AIDS. 1996 Aug; 10(9):959-65. View on Pubmed
  191. Chin DP, Osmond D, Page-Shafer K, Glassroth J, Rosen MJ, Reichman LB, Kvale PA, Wallace JM, Poole WK, Hopewell PC. Reliability of anergy skin testing in persons with HIV infection. The pulmonary Complications of HIV Infection Study Group. Am J Respir Crit Care Med. 1996 Jun; 153(6 Pt 1):1982-4. View on Pubmed
  192. Osmond DH, Page K, Wiley J, Garrett K, Sheppard HW, Moss AR, Schrager L, Winkelstein W. HIV infection in homosexual and bisexual men 18 to 29 years of age: the San Francisco Young Men's Health Study. Am J Public Health. 1994 Dec; 84(12):1933-7. View on Pubmed
  193. Lang W, Osmond D, Page-Bodkin K, Moss A, Winkelstein W. Population-based estimates of antiretroviral therapy and anti-Pneumocystis prophylaxis in San Francisco: 1991. J Acquir Immune Defic Syndr (1988). 1993 Feb; 6(2):191-5. View on Pubmed
  194. Osmond DH, Charlebois E, Sheppard HW, Page K, Winkelstein W, Moss AR, Reingold A. Comparison of risk factors for hepatitis C and hepatitis B virus infection in homosexual men. J Infect Dis. 1993 Jan; 167(1):66-71. View on Pubmed
  195. Page-Bodkin K, Tappero J, Samuel M, Winkelstein W. Kaposi's sarcoma and faecal-oral exposure. Lancet. 1992 Jun 13; 339(8807):1490.